Courier Capital LLC Pfizer Inc Transaction History

Courier Capital LLC

$1.44 Billion
Q3 2024

A detailed history of Courier Capital LLC transactions in Pfizer Inc stock. As of the latest transaction made, Courier Capital LLC holds 59,618 shares of PFE stock, worth $1.59 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

59,618

Previous 60,882 2.08%

Holding current value

$1.59 Million

Previous $1.7 Million 1.29%

% of portfolio

0.12%

Previous 0.14%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$27.7 - $31.39 $35,012 - $39,676	-1,264 Reduced 2.08%	59,618 $1.73 Million
Q2 2024 Jul 23, 2024	SELL	$25.26 - $29.6 $78,103 - $91,523	-3,092 Reduced 4.83%	60,882 $1.7 Million
Q1 2024 Apr 15, 2024	SELL	$25.89 - $29.73 $1.51 Million - $1.73 Million	-58,150 Reduced 47.62%	63,974 $1.78 Million
Q4 2023 Jan 17, 2024	SELL	$26.13 - $33.94 $110,817 - $143,939	-4,241 Reduced 3.36%	122,124 $3.52 Million
Q3 2023 Oct 13, 2023	SELL	$32.09 - $37.51 $48,937 - $57,202	-1,525 Reduced 1.19%	126,365 $4.19 Million
Q2 2023 Jul 31, 2023	BUY	$36.12 - $41.79 $359,068 - $415,434	9,941 Added 8.43%	127,890 $4.69 Million
Q1 2023 May 18, 2023	SELL	$39.39 - $51.28 $204,867 - $266,707	-5,201 Reduced 4.22%	117,949 $4.81 Million
Q4 2022 Jan 24, 2023	SELL	$41.75 - $54.5 $108,466 - $141,591	-2,598 Reduced 2.07%	123,150 $0
Q3 2022 Oct 18, 2022	SELL	$43.76 - $53.42 $34,264 - $41,827	-783 Reduced 0.62%	125,748 $5.5 Million
Q2 2022 Jul 20, 2022	BUY	$46.53 - $55.17 $81,706 - $96,878	1,756 Added 1.41%	126,531 $6.63 Million
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $226,096 - $280,161	-4,942 Reduced 3.81%	124,775 $6.46 Million
Q4 2021 Jan 18, 2022	SELL	$41.32 - $61.25 $192,220 - $284,935	-4,652 Reduced 3.46%	129,717 $7.66 Million
Q3 2021 Oct 14, 2021	SELL	$39.25 - $50.42 $34,383 - $44,167	-876 Reduced 0.65%	134,369 $5.78 Million
Q2 2021 Jul 12, 2021	SELL	$35.91 - $40.68 $150,750 - $170,774	-4,198 Reduced 3.01%	135,245 $5.3 Million
Q1 2021 Apr 12, 2021	BUY	$33.49 - $37.77 $438,116 - $494,107	13,082 Added 10.35%	139,443 $5.05 Million
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $42,172 - $53,625	1,260 Added 1.01%	126,361 $4.65 Million
Q3 2020 Nov 09, 2020	SELL	$31.75 - $37.25 $93,567 - $109,775	-2,947 Reduced 2.3%	125,101 $4.55 Million
Q2 2020 Jul 06, 2020	BUY	$30.12 - $36.54 $178,039 - $215,987	5,911 Added 4.84%	128,048 $4.42 Million
Q1 2020 Apr 22, 2020	SELL	$27.03 - $38.62 $466,564 - $666,619	-17,261 Reduced 12.38%	122,137 $4.35 Million
Q4 2019 Jan 10, 2020	SELL	$32.92 - $37.36 $143,399 - $162,740	-4,356 Reduced 3.03%	139,398 $5.42 Million
Q3 2019 Oct 04, 2019	BUY	$32.49 - $42.13 $99,776 - $129,381	3,071 Added 2.18%	143,754 $5.1 Million
Q2 2019 Jul 16, 2019	SELL	$36.98 - $41.52 $279,346 - $313,642	-7,554 Reduced 5.1%	140,683 $6.09 Million
Q1 2019 Apr 25, 2019	SELL	$37.5 - $41.2 $58,762 - $64,560	-1,567 Reduced 1.05%	148,237 $6.3 Million
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $215,008 - $245,133	-5,589 Reduced 3.6%	149,804 $6.54 Million
Q3 2018 Oct 12, 2018	SELL	$34.47 - $41.81 $123,540 - $149,847	-3,584 Reduced 2.25%	155,393 $6.85 Million
Q2 2018 Jul 19, 2018	SELL	$32.98 - $35.16 $32,155 - $34,281	-975 Reduced 0.61%	158,977 $5.77 Million
Q1 2018 Apr 27, 2018	SELL	$31.91 - $37.02 $25,017 - $29,023	-784 Reduced 0.49%	159,952 $5.68 Million
Q4 2017 Jan 25, 2018	SELL	$33.26 - $35.29 $173,550 - $184,143	-5,218 Reduced 3.14%	160,736 $5.82 Million
Q3 2017 Nov 03, 2017	BUY	$31.0 - $34.15 $3.15 Million - $3.47 Million	101,577 Added 157.78%	165,954 $5.93 Million
Q2 2017 Aug 10, 2017	BUY	N/A	64,377	64,377 $2.16 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Courier Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Courier Capital LLC with notifications on news.

Account

Courier Capital LLC Pfizer Inc Transaction History